Mechanism of inhibitory action of Eldecalcitol, an active vitamin D analog, on bone resorption in vivo

Journal of Steroid Biochemistry and Molecular Biology

Volumn 136, Issue 1, 2013, Pages 171-174

  Takahashi, Naoyuki ^a  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

Author keywords

Bone resorption; Eldecalcitol; Osteoclast precursors; Osteoclasts; RANKL

Indexed keywords

ELDECALCITOL; OSTEOCLAST DIFFERENTIATION FACTOR;

BONE DENSITY; BONE TURNOVER; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; DRUG EFFECT; DRUG MECHANISM; HUMAN; IN VIVO STUDY; JAPAN; LONG TERM EXPOSURE; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PROTEIN EXPRESSION; REVIEW;

MUS;

EID: 84881191033     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2012.11.010     Document Type: Review

References (26)

1. H.F. DeLuca, The vitamin D story: a collaborative effort of basic science and clinical medicine, FASEB Journal 2 (1988) 224-236.
2. R. Bouillon, W.H. Okamura, A.W. Norman, Structure-function relationships in the vitamin D endocrine system, Endocrine Reviews 16 (1995) 200-257.
3. L.G. Raisz, C.L. Trummel, M.F. Holick, H.F. DeLuca, 1, 25-Dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture, Science 175 (1972) 768-769.
4. T. Suda, N. Takahashi, T.J. Martin, Modulation of osteoclast differentiation, Endocrine Reviews 13 (1992) 66-80.
5. M. Shiraki, M. Fukuchi, T. Kiriyama, S. Okamoto, T. Ueno, H. Sakamoto, T. Nagai, Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis, Journal of Bone and Mineral Metabolism 22 (2004) 352-359. (Pubitemid 38980952)
6. T. Matsumoto, T. Miki, H. Hagino, T. Sugimoto, S. Okamoto, T. Hirota, Y. Tani-gawara, Y. Hayashi, M. Fukunaga, M. Shiraki, T. Nakamura, A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial, Journal of Clinical Endocrinology and Metabolism 90 (2005) 5031-5036. (Pubitemid 41262250)
7. T. Matsumoto, N. Kubodera, ED-71, a new active vitamin D3, increases bone mineral density regardless of serum 25(OH)D levels in osteoporotic subjects, Journal of Steroid Biochemistry and Molecular Biology 103 (2007) 584-586. (Pubitemid 46401355)
8. T. Matsumoto, T. Takano, S. Yamakido, F. Takahashi, N. Tsuji, Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism, Journal of Steroid Biochemistry and Molecular Biology 121 (2010) 261-264.
9. S. Harada, T. Mizoguchi, Y. Kobayashi, Y. Nakamichi, S. Takeda, S. Sakai, F. Takahashi, H. Saito, H. Yasuda, N. Udagawa, T. Suda, N. Takahashi, Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone, Journal of Bone and Mineral Research 27 (2012) 461-473.
10. T. Suda, F. Takahashi, N. Takahashi, Bone effects of vitamin D-discrepancies between in vivo and in vitro studies, Archives of Biochemistry and Biophysics 523 (2012)22-29.
11. S. Morimoto, S. Imanaka, E. Koh, T. Shiraishi, T. Nabata, S. Kitano, Y. Miyashita, Y. Nishii, T. Ogihara, Comparison of the inhibitions of proliferation of normal and psoriatic fibroblasts by 1 alpha, 25-dihydroxyvitamin D3 and synthetic analogues of vitamin D3 with an oxygen atom in their side chain, Biochemistry International 19 (1989) 1143-1149. (Pubitemid 19281097)
12. H. Tsurukami, T. Nakamura, K. Suzuki, K. Sato, Y. Higuchi, Y. Nishii, A novel synthetic vitamin D analogue, 2 beta-(3-hydroxypropoxy) 1 alpha, 25-dihydroxyvitamin D3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats, Calcified Tissue International 54 (1994)142-149. (Pubitemid 24046725)
13. Y. Tanaka, T. Nakamura, S. Nishida, K. Suzuki, S. Takeda, K. Sato, Y. Nishii, Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats, Journal of Bone and Mineral Research 11 (1996)325-336. (Pubitemid 26076382)
14. Y. Uchiyama, I.Y. Higuch, S. Takeda, T. Masaki, A. ShiraIshi, K. Sato, N. Kubodera, K. Ikeda, E. Ogata, ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis, Bone 30 (2002)582-588. (Pubitemid 34270495)
15. P.H. de Freitas, T. Hasegawa, S. Takeda, M. Sasaki, C. Tabata, K. Oda, M. Li, H. Saito, N. Amizuka, Eldecalcitol, a second-generation vitamin D analog, drives bone minimodeling and reduces osteoclastic number in trabecular bone of ovariectomized rats, Bone 49 (2011)335-342.
16. T. Okano, N. Tsugawa, S. Masuda, A. Takeuchi, T. Kobayashi, Y. Nishii, Protein-binding properties of 22-oxa-1 alpha, 25-dihydroxyvitamin D3, a synthetic analogue of 1 alpha, 25-dihydroxyvitamin D3, Journal of Nutritional Science and Vitaminology 35 (1989) 529-533. (Pubitemid 20101820)
17. K. Miyamoto, E. Murayama, K. Ochi, H. Watanabe, N. Kubodera, Synthetic studies of vitamin D analogues. XIV. Synthesis and calcium regulating activity of vitamin D3 analogues bearing a hydroxyalkoxy group at the 2 beta-position, Chemical and Pharmaceutical Bulletin 41 (1993) 1111-1113. (Pubitemid 23240095)
18. 3 (ED-71), Journal of Steroid Biochemistry and Molecular Biology 103 (2007) 222-226. (Pubitemid 46401295)
19. S. Harada, S. Takeda, A. Uno, F. Takahashi, H. Saito, Eldecalcitol is less effective in suppressing parathyroid hormone compared to calcitriol in vivo, Journal of Steroid Biochemistry and Molecular Biology 121 (2010) 281-283.
20. M. Fukushima, Y. Nishil, M. Suzuki, T. Suda, Comparative studies on the 25-hydroxylations of cholecalciferol and 1 alpha-hydroxycholecalfierol in perfused rat liver, Biochemical Journal 170 (1978) 495-502. (Pubitemid 8290543)
21. T. Suda, N. Takahashi, N. Udagawa, E. Jimi, M.T. Gillespie, T.J. Martin, Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families, Endocrine Reviews 20 (1999) 345-357. (Pubitemid 30649812)
22. W.J. Boyle, W.S. Simonet, D.L. Lacey, Osteoclast differentiation and activation, Nature 423 (2003) 337-342. (Pubitemid 40852708)
23. T. Mizoguchi, A. Muto, N. Udagawa, A. Arai, T. Yamashita, A. Hosoya, T. Ninomiya, H. Nakamura, Y. Yamamoto, S. Kinugawa, M. Nakamura, Y. Nakamichi, Y. Kobayashi, S. Nagasawa, K. Oda, H. Tanaka, M. Tagaya, J.M. Penninger, M. Ito, N. Takahashi, Identification of cell cycle-arrested quiescent osteoclast precursors in vivo, Journal of Cell Biology 184 (2009) 541-554.
24. A. Muto, T. Mizoguchi, N. Udagawa, S. Ito, I. Kawahara, Y. Abiko, A. Arai, S. Harada, Y. Kobayashi, Y. Nakamichi, J.M. Penninger, T. Noguchi, N. Takahashi, Lineage-committed osteoclast precursors circulate in blood and settle down into bone, Journal of Bone and Mineral Research 26 (2011) 2978-2990.
25. A. Arai, T. Mizoguchi, S. Harada, Y. Kobayashi, Y. Nakamichi, H. Yasuda, J.M. Penninger, K. Yamada, N. Udagawa, N. Takahashi, c-Fos plays an essential role in the up-regulation of RANK expression in osteoclast precursors within the bone microenvironment, Journal of Cell Science 125 (Pt 12) (2012) 2910-2917.
26. Y. Nakamichi, T. Mizoguchi, A. Arai, Y. Kobayashi, M. Sato, J.M. Penninger, H. Yasuda, S. Kato, H.F. Deluca, T. Suda, N. Udagawa, N. Takahashi, Spleen serves as a reservoir of osteoclast precursors through vitamin D-inducedIL-34 expression in osteopetrotic op/op mice, Proceedings of the National Academy of Sciences ofthe United States of America 109 (2012) 10006-10011.